Literature DB >> 7918682

A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).

A M Scanu1, D Pfaffinger, J C Lee, J Hinman.   

Abstract

Human lipoprotein(a) or Lp(a) binds, like plasminogen, to lysine Sepharose. However, contrary to plasminogen in which kringles 1 and 4 have been implicated, the binding site or sites on apo(a), the specific glycoprotein of Lp(a), have not been determined. For the first time we now report the occurrence of a human Lp(a) that has a mutant form of apo(a) where Arg has replaced Trp in position 72 of kringle 4-37 and is unable to bind to lysine Sepharose. This observation suggests that Trp72 of apo(a) kringle 4-37 may play a dominant role in lysine binding. Lysine binding has been associated with the thrombogenic potential of Lp(a). Thus, the Trp72-->Arg mutation may render Lp(a) 'benign' from the cardiovascular viewpoint.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918682     DOI: 10.1016/0925-4439(94)90104-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.

Authors:  O Klezovitch; C Edelstein; A M Scanu
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Convergent evolution of apolipoprotein(a) in primates and hedgehog.

Authors:  R M Lawn; K Schwartz; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.

Authors:  S D Hughes; X J Lou; S Ighani; J Verstuyft; D J Grainger; R M Lawn; E M Rubin
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.

Authors:  N W Boonmark; X J Lou; Z J Yang; K Schwartz; J L Zhang; E M Rubin; R M Lawn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding.

Authors:  Q Ye; M N Rahman; M L Koschinsky; Z Jia
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

6.  Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).

Authors:  Gregor Leibundgut; Corey Scipione; Huiyong Yin; Matthias Schneider; Michael B Boffa; Simone Green; Xiaohong Yang; Edward Dennis; Joseph L Witztum; Marlys L Koschinsky; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

7.  Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.

Authors:  A Hermann; W R Laws; P C Harpel
Journal:  Protein Sci       Date:  1997-11       Impact factor: 6.725

Review 8.  The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events.

Authors:  A M Scanu
Journal:  Curr Cardiol Rep       Date:  2001-09       Impact factor: 2.931

Review 9.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

10.  LPA and PLG sequence variation and kringle IV-2 copy number in two populations.

Authors:  Dana C Crawford; Ze Peng; Jan-Fang Cheng; Dario Boffelli; Magdalena Ahearn; Dan Nguyen; Tristan Shaffer; Qian Yi; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Hum Hered       Date:  2008-07-09       Impact factor: 0.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.